Tien-li Lee serves as Executive at Aardvark Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Tien-li Lee has executed 9 insider transactions totaling $358.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 9, 2026 involved receiving (via award) 203,851 shares valued at $0.
Tien-li Lee currently holds 203,851 shares of Aardvark Therapeutics, Inc. (AARD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tien-li Lee has been a net buyer of AARD stock. They have purchased $358.6K and sold $0 worth of shares.
Tien-li Lee's most recent insider trade was on Feb 9, 2026, when they sold 203,851 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $14.49 |
| Discretionary |
| Oct 15, 2025 | AARD | $5.2K | Option Exercise | 1,229 | $4.24 | Discretionary |
| Sep 15, 2025 | AARD | $34.8K | Purchase | 3,500 | $9.94 | Discretionary |
| Sep 15, 2025 | AARD | $61.8K | Purchase | 6,500 | $9.51 | Discretionary |
| Sep 12, 2025 | AARD | $42.5K | Purchase | 5,000 | $8.50 | Discretionary |
| Sep 11, 2025 | AARD | $46.9K | Purchase | 6,000 | $7.82 | Discretionary |
| Sep 10, 2025 | AARD | $71.2K | Purchase | 9,000 | $7.91 | Discretionary |
| Aug 28, 2025 | AARD | $73.0K | Option Exercise | 17,209 | $4.24 | Discretionary |